NDC 60687-631-11 - Metoclopramide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60687-631
- Requested NDC
- 60687-631-11
- Package NDCs from labels
- 60687-631-11, 60687-631-01
- Manufacturer
- American Health Packaging
- Effective date
- 2024-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide - American Health Packaging | American Health Packaging | 2024-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-631-01 | Metoclopramide | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 60687-631-11 | Metoclopramide | 1 in 1 BLISTER PACK | TABLET | 1 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-631-01 | EA - Each | 60687-631 | 63bc86ae-c05d-4c31-b52b-c369a62b8049 | 1 | 2022-02-07 |
| 60687-631-11 | EA - Each | 60687-631 | 0723c6dc-a447-4b88-9582-44efbc705a8d | 1 | 2022-02-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metoclopramide | METOCLOPRAMIDE | Aphena Pharma Solutions - Tennessee, LLC | 595439ae-cf01-821c-e063-6294a90af16a | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | ANDA070184 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Redpharm Drug | 58e70a1b-ac93-ff1d-e063-6394a90aa2da | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | NuCare Pharmaceuticals,Inc. | 58b3666f-ac0f-811e-e063-6394a90a8e04 | 2026-08-10 | Boxed warning, Warnings, Adverse reactions | 311668 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | REMEDYREPACK INC. | 5d31d815-50fa-4e78-8ebd-affc2514ce78 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | ANDA070184 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | American Health Packaging | 0034a97a-fb05-418a-a234-de278907cd2a | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Ipca Laboratories Limited | c143e210-4ce7-44e5-b1e2-bf0e6bfde485 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 311668 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | ATLANTIC BIOLOGICALS CORP. | 3cd4b274-6176-4e5b-9765-4f50763bd58f | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Preferred Pharmaceuticals Inc. | 697ec7b1-945a-4a31-b585-f051dc246165 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | ANDA070184 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | NuCare Pharmaceuticals, Inc. | 548e83bc-898f-6b16-e063-6294a90a1755 | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | 311668 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | Avenacy, LLC | dc4a13f8-1e9b-4c75-82c0-bcd11f0a9a66 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Cardinal Health 107, LLC | 7eeaa7bc-c94f-47d0-94e5-e35ccadca19e | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | ANDA072801 311668 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Coupler LLC | 5345905d-18b0-1e42-e063-6394a90af745 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | ANDA070184 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Coupler LLC | 5345a125-0cee-472e-e063-6394a90aeb21 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | ANDA072801 311668 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Safecor Health LLC | 15d616d7-2f4c-4882-a03c-fcc86c18f5f8 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | ANDA070184 ANDA072801 311668 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 146803a1-199d-4789-b128-e974bdd03322 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | REMEDYREPACK INC. | 6637cb78-d50a-4dbf-8fb7-b1b5102c5c5f | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | ANDA070184 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | ANI Pharmaceuticals, Inc. | 797aad80-0597-42f8-99d5-39de180c3b5a | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 311668 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | ScieGen Pharmaceuticals, Inc. | b16ad17c-eeea-407e-91e4-36506e9aa698 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 311668 311666 W1792A2RVD |
| METOCLOPRAMIDE | METOCLOPRAMIDE HYDROCHLORIDE | Henry Schein, Inc. | f50c8fb4-23c4-4762-95bb-e4ca7b289a4d | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 50a3cf38-66dc-4fa5-8a45-adf959c987ab | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.